Syros Pharmaceuticals (0S90) Financial Statements

2 Followers

Syros Pharmaceuticals Financial Overview

Syros Pharmaceuticals's market cap is currently €9.23K. The company's EPS TTM is €; its P/E ratio is ―; Syros Pharmaceuticals is scheduled to report earnings on ―, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 9.94M	$ 14.88M	$ 23.49M	$ 15.09M	$ 1.98M
Gross Profit	$ 7.68M	$ 11.91M	$ 23.49M	$ 15.09M	$ 1.98M
Operating Income	$ -128.99M	$ -135.87M	$ -99.42M	$ -82.30M	$ -77.74M
EBITDA	$ -157.19M	$ -87.55M	$ -79.63M	$ -79.21M	$ -72.72M
Net Income	$ -164.57M	$ -94.65M	$ -86.56M	$ -84.04M	$ -75.44M
Balance Sheet
Cash & Short-Term Investments	$ 139.53M	$ 202.30M	$ 130.37M	$ 173.98M	$ 91.42M
Total Assets	$ 168.17M	$ 244.49M	$ 182.94M	$ 213.25M	$ 149.98M
Total Debt	$ 62.08M	$ 63.57M	$ 65.19M	$ 66.21M	$ 25.92M
Net Debt	$ -77.45M	$ -103.90M	$ -27.11M	$ -107.77M	$ -15.52M
Total Liabilities	$ 151.51M	$ 116.75M	$ 97.72M	$ 122.70M	$ 70.79M
Stockholders' Equity	$ 16.66M	$ 127.74M	$ 85.22M	$ 90.55M	$ 79.18M
Cash Flow
Free Cash Flow	$ -109.98M	$ -124.31M	$ -100.78M	$ -60.70M	$ -72.89M
Operating Cash Flow	$ -109.71M	$ -123.06M	$ -99.54M	$ -57.36M	$ -60.25M
Investing Cash Flow	$ 37.34M	$ 67.19M	$ -52.65M	$ 46.66M	$ -11.73M
Financing Cash Flow	$ 43.46M	$ 131.04M	$ 70.51M	$ 142.95M	$ 65.99M

Currency in USD

Syros Pharmaceuticals Earnings and Revenue History

Income Statement >

Syros Pharmaceuticals Debt to Assets

Balance Sheet >

Syros Pharmaceuticals Cash Flow

Cash Flow >

Syros Pharmaceuticals Forecast EPS vs Actual EPS

Earnings >